Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sotera Health (SHC) Shares Outstanding (Weighted Average) (2019 - 2026)

Sotera Health has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $284.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.41% year-over-year to $284.0 million; the TTM value through Dec 2025 reached $284.0 million, changed 0.41%, while the annual FY2025 figure was $284.0 million, 0.41% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $284.0 million at Sotera Health, roughly flat from $284.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $284.1 million in Q3 2025 and troughed at $278.8 million in Q1 2021.
  • A 5-year average of $281.2 million and a median of $280.8 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 20.09% in 2021 and later increased 0.29% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $279.2 million in 2021, then increased by 0.31% to $280.1 million in 2022, then rose by 0.33% to $281.0 million in 2023, then rose by 0.63% to $282.8 million in 2024, then grew by 0.41% to $284.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SHC at $284.0 million in Q4 2025, $284.1 million in Q3 2025, and $283.7 million in Q2 2025.